BRIAN WADE: Open Payments
NPI 1114641370 · GRANTS PASS, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$193 in 9 payments from 8 companies in 2025. Trend: 2023 $25 · 2024 $0 · 2025 $193
Food & beverage: $193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $36 |
| Lundbeck LLC | 1 | $27 |
| Alkermes, Inc. | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: REXULTI, VRAYLAR, LYBALVI, Auvelity, CAPLYTA, FANAPT, INGREZZA.
Industry payments across OR — which companies pay providers there.
